共 50 条
Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
被引:0
|作者:
Hazlewood, Glen S.
[1
,2
,3
,4
]
机构:
[1] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[2] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Arthritis Res Canada, Richmond, BC, Canada
[4] McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada
关键词:
D O I:
10.1093/rheumatology/kead388
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
引用
收藏
页码:3773 / 3775
页数:3
相关论文